Scleroderma

Systemic Sclerosis Mortality Data Reveals Trends Over 48 Years

Researchers identified secular trends associated with systemic sclerosis mortality over 48 years.

Perceptions, Practices in RA-ILD Differ Between Rheumatologists and Pulmonologists

There are significant differences in perceptions of prevalence, risk factors, and the management of RA-associated interstitial lung disease between rheumatologists and pulmonologists.

Role of Lung Ultrasound in the Assessment of Interstitial Lung Disease in Systemic Sclerosis

In this systematic review, researchers assessed the role of lung ultrasound in the assessment of interstitial lung disease in systemic sclerosis.

Antibody Response Against Human Cytomegalovirus Differs by Anti-Ro52 Antibody Status in SSc

Researchers investigated the association between anti-Ro52 antibodies with responses to specific human cytomegalovirus antigens in systemic sclerosis and lupus.

Case Report: Anti-Ku Antibodies Identified in Systemic Sclerosis-Polymyositis Overlap Syndrome in an Adolescent

Authors of a report presented the case of systemic sclerosis-polymyositis overlap syndrome in an adolescent with anti-Ku antibodies.

Cancer Screening Strategies in Rheumatic Diseases: Expert Perspectives

Experts highlight the need for cancer screening strategies in patients with rheumatic diseases.

Use of Nail Videocapillaroscopy and Digital Thermal Monitoring for Microangiopathy Quantification in Raynaud Phenomenon in SSc

Researchers evaluated the correlation of nail videocapillaroscopy patterns and digital thermal monitoring variables in systemic sclerosis.

Assessing the Performance of Pulmonary Function Tests for Detection of ILD in Diffuse Cutaneous SSc

Researchers assessed the performance of pulmonary function tests for the detection of interstitial lung disease in early diffuse cutaneous systemic sclerosis.

Long-Term Efficacy of Methotrexate Demonstrated in Pediatric Linear Scleroderma

Researchers evaluated disease course and long-term efficacy of methotrexate treatment in children with linear scleroderma.

Treatment With Mycophenolate Mofetil and Cyclophosphamide Improves Patient-Reported Outcomes in Scleroderma Lung Disease

Researchers determined the effect of treatment with cyclophosphamide and mycophenolate mofetil on patient-reported outcomes in systemic sclerosis-related interstitial lung disease.